These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 30617121)

  • 101. Vaccination of older adults: Influenza, pneumococcal disease, herpes zoster, COVID-19 and beyond.
    Weinberger B
    Immun Ageing; 2021 Oct; 18(1):38. PubMed ID: 34627326
    [TBL] [Abstract][Full Text] [Related]  

  • 102. The impact of human vaccines on bacterial antimicrobial resistance. A review.
    Jansen KU; Gruber WC; Simon R; Wassil J; Anderson AS
    Environ Chem Lett; 2021; 19(6):4031-4062. PubMed ID: 34602924
    [TBL] [Abstract][Full Text] [Related]  

  • 103. Mutation Rates, Mutation Frequencies, and Proofreading-Repair Activities in RNA Virus Genetics.
    Domingo E; García-Crespo C; Lobo-Vega R; Perales C
    Viruses; 2021 Sep; 13(9):. PubMed ID: 34578463
    [TBL] [Abstract][Full Text] [Related]  

  • 104. Co-Ordination of Mucosal B Cell and CD8 T Cell Memory by Tissue-Resident CD4 Helper T Cells.
    Son YM; Sun J
    Cells; 2021 Sep; 10(9):. PubMed ID: 34572004
    [TBL] [Abstract][Full Text] [Related]  

  • 105. Conserved Sequence Analysis of Influenza A Virus HA Segment and Its Application in Rapid Typing.
    Lin Q; Ji X; Wu F; Ma L
    Diagnostics (Basel); 2021 Jul; 11(8):. PubMed ID: 34441263
    [TBL] [Abstract][Full Text] [Related]  

  • 106. Exploiting Pan Influenza A and Pan Influenza B Pseudotype Libraries for Efficient Vaccine Antigen Selection.
    Del Rosario JMM; da Costa KAS; Asbach B; Ferrara F; Ferrari M; Wells DA; Mann GS; Ameh VO; Sabeta CT; Banyard AC; Kinsley R; Scott SD; Wagner R; Heeney JL; Carnell GW; Temperton NJ
    Vaccines (Basel); 2021 Jul; 9(7):. PubMed ID: 34358157
    [TBL] [Abstract][Full Text] [Related]  

  • 107. Site-Specific Glycan-Masking/Unmasking Hemagglutinin Antigen Design to Elicit Broadly Neutralizing and Stem-Binding Antibodies Against Highly Pathogenic Avian Influenza H5N1 Virus Infections.
    Chen TH; Yang YL; Jan JT; Chen CC; Wu SC
    Front Immunol; 2021; 12():692700. PubMed ID: 34335603
    [TBL] [Abstract][Full Text] [Related]  

  • 108. Targeting the Host Response: Can We Manipulate Extracellular Matrix Metalloproteinase Activity to Improve Influenza Virus Infection Outcomes?
    Pedrina J; Stambas J
    Front Mol Biosci; 2021; 8():703456. PubMed ID: 34291090
    [TBL] [Abstract][Full Text] [Related]  

  • 109. Intranasal Nanoparticle Vaccination Elicits a Persistent, Polyfunctional CD4 T Cell Response in the Murine Lung Specific for a Highly Conserved Influenza Virus Antigen That Is Sufficient To Mediate Protection from Influenza Virus Challenge.
    Nelson SA; Dileepan T; Rasley A; Jenkins MK; Fischer NO; Sant AJ
    J Virol; 2021 Jul; 95(16):e0084121. PubMed ID: 34076479
    [TBL] [Abstract][Full Text] [Related]  

  • 110. Epitope-targeting platform for broadly protective influenza vaccines.
    Zeigler DF; Gage E; Clegg CH
    PLoS One; 2021; 16(5):e0252170. PubMed ID: 34043704
    [TBL] [Abstract][Full Text] [Related]  

  • 111. Persistently high antibody responses after AS03-adjuvanted H1N1pdm09 vaccine: Dissecting the HA specific antibody response.
    Madsen A; Jul-Larsen Å; Trieu MC; Krammer F; Cox RJ
    NPJ Vaccines; 2021 Apr; 6(1):45. PubMed ID: 33795694
    [TBL] [Abstract][Full Text] [Related]  

  • 112. Coronavirus-Specific Antibody Cross Reactivity in Rhesus Macaques Following SARS-CoV-2 Vaccination and Infection.
    Jacob-Dolan C; Feldman J; McMahan K; Yu J; Zahn R; Wegmann F; Schuitemaker H; Schmidt AG; Barouch DH
    J Virol; 2021 May; 95(11):. PubMed ID: 33692201
    [TBL] [Abstract][Full Text] [Related]  

  • 113. Adjuvantation of Influenza Vaccines to Induce Cross-Protective Immunity.
    Li Z; Zhao Y; Li Y; Chen X
    Vaccines (Basel); 2021 Jan; 9(2):. PubMed ID: 33494477
    [TBL] [Abstract][Full Text] [Related]  

  • 114. Chimeric Hemagglutinin-Based Live-Attenuated Vaccines Confer Durable Protective Immunity against Influenza A Viruses in a Preclinical Ferret Model.
    Liu WC; Nachbagauer R; Stadlbauer D; Strohmeier S; Solórzano A; Berlanda-Scorza F; Innis BL; García-Sastre A; Palese P; Krammer F; Albrecht RA
    Vaccines (Basel); 2021 Jan; 9(1):. PubMed ID: 33440898
    [TBL] [Abstract][Full Text] [Related]  

  • 115. Tissue-resident CD4
    Son YM; Cheon IS; Wu Y; Li C; Wang Z; Gao X; Chen Y; Takahashi Y; Fu YX; Dent AL; Kaplan MH; Taylor JJ; Cui W; Sun J
    Sci Immunol; 2021 Jan; 6(55):. PubMed ID: 33419791
    [TBL] [Abstract][Full Text] [Related]  

  • 116. Anti-Influenza Strategies Based on Nanoparticle Applications.
    Wieczorek K; Szutkowska B; Kierzek E
    Pathogens; 2020 Dec; 9(12):. PubMed ID: 33287259
    [TBL] [Abstract][Full Text] [Related]  

  • 117. Injectable Hydrogels for Sustained Codelivery of Subunit Vaccines Enhance Humoral Immunity.
    Roth GA; Gale EC; Alcántara-Hernández M; Luo W; Axpe E; Verma R; Yin Q; Yu AC; Lopez Hernandez H; Maikawa CL; Smith AAA; Davis MM; Pulendran B; Idoyaga J; Appel EA
    ACS Cent Sci; 2020 Oct; 6(10):1800-1812. PubMed ID: 33145416
    [TBL] [Abstract][Full Text] [Related]  

  • 118. Progress in the Development of Universal Influenza Vaccines.
    Sun W; Luo T; Liu W; Li J
    Viruses; 2020 Sep; 12(9):. PubMed ID: 32957468
    [TBL] [Abstract][Full Text] [Related]  

  • 119. Insights from the comparison of genomic variants from two influenza B viruses grown in the presence of human antibodies in cell culture.
    Plant EP; Manukyan H; Laassri M; Ye Z
    PLoS One; 2020; 15(9):e0239015. PubMed ID: 32925936
    [TBL] [Abstract][Full Text] [Related]  

  • 120. Self-Assembly M2e-Based Peptide Nanovaccine Confers Broad Protection Against Influenza Viruses.
    Wang Q; Zhang Y; Zou P; Wang M; Fu W; She J; Song Z; Xu J; Huang J; Wu F
    Front Microbiol; 2020; 11():1961. PubMed ID: 32922379
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.